These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37988664)

  • 1. Germline PRKACA amplification-associated primary pigmented nodular adrenocortical disease: a case report and literature review.
    Yang WR; Liang XH; Qin YF; Yang HY; He SZ; Huang ZX; Liu YP; Luo ZJ
    Arch Endocrinol Metab; 2023 Nov; 68():e220491. PubMed ID: 37988664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A girl with Cushing's syndrome due to primary pigmented nodular adrenocortical disease].
    Bocca G; van Mil EG; Voorhoeve PG; Wijnaendts LC; Delemarre-van de Waal HA
    Ned Tijdschr Geneeskd; 2006 Oct; 150(43):2390-3. PubMed ID: 17100132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical characteristics and pathogenic variants of primary pigmented nodular adrenocortical disease in 210 patients: a systematic review.
    Sun J; Ding L; He L; Fu H; Li R; Feng J; Dong J; Liao L
    Front Endocrinol (Lausanne); 2024; 15():1356870. PubMed ID: 39006359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease.
    Groussin L; Jullian E; Perlemoine K; Louvel A; Leheup B; Luton JP; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4324-9. PubMed ID: 12213893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline PRKACA amplification causes variable phenotypes that may depend on the extent of the genomic defect: molecular mechanisms and clinical presentations.
    Lodish MB; Yuan B; Levy I; Braunstein GD; Lyssikatos C; Salpea P; Szarek E; Karageorgiadis AS; Belyavskaya E; Raygada M; Faucz FR; Izzat L; Brain C; Gardner J; Quezado M; Carney JA; Lupski JR; Stratakis CA
    Eur J Endocrinol; 2015 Jun; 172(6):803-11. PubMed ID: 25924874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRKAR1A mutations in primary pigmented nodular adrenocortical disease.
    Cazabat L; Ragazzon B; Groussin L; Bertherat J
    Pituitary; 2006; 9(3):211-9. PubMed ID: 17036196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial Forms of Cushing Syndrome in Primary Pigmented Nodular Adrenocortical Disease Presenting with Short Stature and Insidious Symptoms: A Clinical Series.
    Navarro Moreno C; Delestienne A; Marbaix E; Aydin S; Hörtnagel K; Lechner S; Sznajer Y; Beauloye V; Maiter D; Lysy PA
    Horm Res Paediatr; 2018; 89(6):423-433. PubMed ID: 29909407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Children with Cushing's syndrome: Primary Pigmented Nodular Adrenocortical Disease should always be suspected.
    da Silva RM; Pinto E; Goldman SM; Andreoni C; Vieira TC; Abucham J
    Pituitary; 2011 Mar; 14(1):61-7. PubMed ID: 20924687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary pigmented nodular adrenocortical disease (PPNAD): single centre experience.
    Memon SS; Thakkar K; Patil V; Jadhav S; Lila AR; Fernandes G; Bandgar TR; Shah NS
    J Pediatr Endocrinol Metab; 2019 Apr; 32(4):391-397. PubMed ID: 30875328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of dexamethasone suppression test during the diagnosis of primary pigmented nodular adrenocortical disease in Chinese adrenocorticotropic hormone-independent Cushing syndrome.
    Chen S; Li R; Lu L; Duan L; Zhang X; Tong A; Pan H; Zhu H; Lu Z
    Endocrine; 2018 Jan; 59(1):183-190. PubMed ID: 29094256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carney Complex Complicated with Primary Pigmented Nodular Adrenocortical Disease without Cushing's Syndrome Recurrence for Five Years after Unilateral Adrenalectomy.
    Tsurutani Y; Kiriyama K; Kondo M; Hasebe M; Sata A; Mizuno Y; Sugisawa C; Saito J; Nishikawa T
    Intern Med; 2022; 61(2):205-211. PubMed ID: 35034934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenal pathophysiology: lessons from the Carney complex.
    Groussin L; Cazabat L; René-Corail F; Jullian E; Bertherat J
    Horm Res; 2005; 64(3):132-9. PubMed ID: 16192737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor.
    Bourdeau I; Lacroix A; Schürch W; Caron P; Antakly T; Stratakis CA
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3931-7. PubMed ID: 12915689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary pigmented nodular adrenocortical disease: reevaluation of a patient with carney complex 27 years after unilateral adrenalectomy.
    Sarlis NJ; Chrousos GP; Doppman JL; Carney JA; Stratakis CA
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1274-8. PubMed ID: 9100606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity?
    Gunther DF; Bourdeau I; Matyakhina L; Cassarino D; Kleiner DE; Griffin K; Courkoutsakis N; Abu-Asab M; Tsokos M; Keil M; Carney JA; Stratakis CA
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3173-82. PubMed ID: 15240590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An unusual presentation of Carney complex with diffuse primary pigmented nodular adrenocortical disease on one adrenal gland and a nonpigmented adrenocortical adenoma and focal primary pigmented nodular adrenocortical disease on the other.
    Tung SC; Hwang DY; Yang JW; Chen WJ; Lee CT
    Endocr J; 2012; 59(9):823-30. PubMed ID: 22785148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral Adrenocortical Nodular Disease and Cushing's Syndrome.
    Bouys L; Violon F; Louiset E; Sibony M; Lefebvre H; Bertherat J
    J Clin Endocrinol Metab; 2024 Sep; 109(10):2422-2432. PubMed ID: 38888184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carney complex, a familial Cushing's syndrome due to primary pigmented nodular adrenocortical disease: a case report.
    Hsin SC; Hsieh MC; Hwang SJ; Hsia PJ; Tsay KB; Shin SL
    Kaohsiung J Med Sci; 2002 Dec; 18(12):627-31. PubMed ID: 12670039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline PRKACA amplification leads to Cushing syndrome caused by 3 adrenocortical pathologic phenotypes.
    Carney JA; Lyssikatos C; Lodish MB; Stratakis CA
    Hum Pathol; 2015 Jan; 46(1):40-9. PubMed ID: 25449630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases.
    Thiel A; Reis AC; Haase M; Goh G; Schott M; Willenberg HS; Scholl UI
    Eur J Endocrinol; 2015 Jun; 172(6):677-85. PubMed ID: 25750087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.